SU‐E‐T‐385: Comparison of Breast Radiotherapy Induced Secondary Cancer Risk for 3D‐Conformal Therapy, IMRT and VMAT

B. Lee, J. Sung, Myonggeun Yoon

Research output: Contribution to journalArticle

Abstract

Purpose: The objective of this study was to evaluate the secondary cancer risk of various organs due to the radiation treatment of breast cancer. Methods: The organ doses were measured with photoluminescent dosimeter (PLD) in anthropomorphic phantom for the treatment of breast cancer with 3D conformal radiation therapy (3D), intensity‐modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT). The cancer risk based on measured dose was calculated using the BEIR (Biological Effects of Ionizing Radiation) VII models which yield lifetime attributable risks (LAR) for radiotherapy techniques. Results: The secondary dose per treatment dose (50.4 Gy) from 3D‐CRT in various organs ranged from 0.02 to 0.36 Gy. The secondary doses per treatment dose from IMRT and RapidArc, however, ranged between 0.07 and 8.48 Gy, indicating that IMRT and RapidArc are associated with higher doses of secondary radiation than 3D‐CRT. The organ specific LARs of the thyroid, contralateral breast and ipsilateral lung were 0.02, 19.76, 0.74 per 100,000 population in 3D‐CRT which is much lower compared with IMRT (0.11, 463.6, 10.2) or RapidArc (0.11, 290.37, 11.71). Conclusion: The overall estimation of LAR indicated that the radiation‐induced cancer risk due to the beast radiation therapy was lower with 3D‐CRT than with IMRT or RapidArc.

Original languageEnglish
Number of pages1
JournalMedical Physics
Volume40
Issue number6
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Intensity-Modulated Radiotherapy
Breast
Radiotherapy
Neoplasms
Therapeutics
Radiation
Breast Neoplasms
Ionizing Radiation
Thyroid Gland
Lung

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐385 : Comparison of Breast Radiotherapy Induced Secondary Cancer Risk for 3D‐Conformal Therapy, IMRT and VMAT. / Lee, B.; Sung, J.; Yoon, Myonggeun.

In: Medical Physics, Vol. 40, No. 6, 01.01.2013.

Research output: Contribution to journalArticle

@article{f3dc0b8e73a746f8ac84b0ad3aeb7379,
title = "SU‐E‐T‐385: Comparison of Breast Radiotherapy Induced Secondary Cancer Risk for 3D‐Conformal Therapy, IMRT and VMAT",
abstract = "Purpose: The objective of this study was to evaluate the secondary cancer risk of various organs due to the radiation treatment of breast cancer. Methods: The organ doses were measured with photoluminescent dosimeter (PLD) in anthropomorphic phantom for the treatment of breast cancer with 3D conformal radiation therapy (3D), intensity‐modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT). The cancer risk based on measured dose was calculated using the BEIR (Biological Effects of Ionizing Radiation) VII models which yield lifetime attributable risks (LAR) for radiotherapy techniques. Results: The secondary dose per treatment dose (50.4 Gy) from 3D‐CRT in various organs ranged from 0.02 to 0.36 Gy. The secondary doses per treatment dose from IMRT and RapidArc, however, ranged between 0.07 and 8.48 Gy, indicating that IMRT and RapidArc are associated with higher doses of secondary radiation than 3D‐CRT. The organ specific LARs of the thyroid, contralateral breast and ipsilateral lung were 0.02, 19.76, 0.74 per 100,000 population in 3D‐CRT which is much lower compared with IMRT (0.11, 463.6, 10.2) or RapidArc (0.11, 290.37, 11.71). Conclusion: The overall estimation of LAR indicated that the radiation‐induced cancer risk due to the beast radiation therapy was lower with 3D‐CRT than with IMRT or RapidArc.",
author = "B. Lee and J. Sung and Myonggeun Yoon",
year = "2013",
month = "1",
day = "1",
doi = "10.1118/1.4814819",
language = "English",
volume = "40",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐385

T2 - Comparison of Breast Radiotherapy Induced Secondary Cancer Risk for 3D‐Conformal Therapy, IMRT and VMAT

AU - Lee, B.

AU - Sung, J.

AU - Yoon, Myonggeun

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Purpose: The objective of this study was to evaluate the secondary cancer risk of various organs due to the radiation treatment of breast cancer. Methods: The organ doses were measured with photoluminescent dosimeter (PLD) in anthropomorphic phantom for the treatment of breast cancer with 3D conformal radiation therapy (3D), intensity‐modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT). The cancer risk based on measured dose was calculated using the BEIR (Biological Effects of Ionizing Radiation) VII models which yield lifetime attributable risks (LAR) for radiotherapy techniques. Results: The secondary dose per treatment dose (50.4 Gy) from 3D‐CRT in various organs ranged from 0.02 to 0.36 Gy. The secondary doses per treatment dose from IMRT and RapidArc, however, ranged between 0.07 and 8.48 Gy, indicating that IMRT and RapidArc are associated with higher doses of secondary radiation than 3D‐CRT. The organ specific LARs of the thyroid, contralateral breast and ipsilateral lung were 0.02, 19.76, 0.74 per 100,000 population in 3D‐CRT which is much lower compared with IMRT (0.11, 463.6, 10.2) or RapidArc (0.11, 290.37, 11.71). Conclusion: The overall estimation of LAR indicated that the radiation‐induced cancer risk due to the beast radiation therapy was lower with 3D‐CRT than with IMRT or RapidArc.

AB - Purpose: The objective of this study was to evaluate the secondary cancer risk of various organs due to the radiation treatment of breast cancer. Methods: The organ doses were measured with photoluminescent dosimeter (PLD) in anthropomorphic phantom for the treatment of breast cancer with 3D conformal radiation therapy (3D), intensity‐modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT). The cancer risk based on measured dose was calculated using the BEIR (Biological Effects of Ionizing Radiation) VII models which yield lifetime attributable risks (LAR) for radiotherapy techniques. Results: The secondary dose per treatment dose (50.4 Gy) from 3D‐CRT in various organs ranged from 0.02 to 0.36 Gy. The secondary doses per treatment dose from IMRT and RapidArc, however, ranged between 0.07 and 8.48 Gy, indicating that IMRT and RapidArc are associated with higher doses of secondary radiation than 3D‐CRT. The organ specific LARs of the thyroid, contralateral breast and ipsilateral lung were 0.02, 19.76, 0.74 per 100,000 population in 3D‐CRT which is much lower compared with IMRT (0.11, 463.6, 10.2) or RapidArc (0.11, 290.37, 11.71). Conclusion: The overall estimation of LAR indicated that the radiation‐induced cancer risk due to the beast radiation therapy was lower with 3D‐CRT than with IMRT or RapidArc.

UR - http://www.scopus.com/inward/record.url?scp=85024774599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024774599&partnerID=8YFLogxK

U2 - 10.1118/1.4814819

DO - 10.1118/1.4814819

M3 - Article

AN - SCOPUS:85024774599

VL - 40

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -